What's new

Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 4, Status: Authorised

Feb 26, 2025 - 14:17
 0
Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics, Online, Europea...

Next Article

NewGen talent shines at London Fashion Week

Related Posts

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Nilotinib product-specific bioequivalence guidance

Nilotinib product-specific bioequivalence guidance

Feb 12, 2025  0

Infectious Diseases Working Party (IDWP) consolidated 3...

Feb 21, 2025  0